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The plants Givotia rottleriformis bark and Cassia tora leaves were used in indigenous medicine in the treatment of 
chronic inflammatory diseases like psoriasis. In previous work, three flavonoids namely Rutin (I), Luteolin-7-O-β-D-
Glucuronide (II) and Kaempferol 3-O-[2-O-(6-O-feruloyl)-β-D-glucopyranosyl]-β-D-galactopyranoside (III) were isolated 
from G. rottleriformis bark and three flavonoids viz quercetin-3-O-β-d-glucuronide (IV), Luteolin-7-O-β-glucopyranoside 
(V) and Formononetin-7-O-β-D-Glucoside (VI) were isolated from C. tora leaves and evaluated for antipsoriatic activity. 
The cytotoxic effect of isolated compounds I-VI was evaluated using HaCaT cells, a rapidly multiplying human keratinocyte 
cell line, as a model of epidermal hyperproliferation in psoriasis. Among the isolated compounds, compound II, III and VI 
showed significant antiproliferant activity in HaCaT cells. Pro-inflammatory cytokines viz., IL-1α, IL-1β, IL-6, IL-8, IL-17 
and TNF-α contributes to the pathogenesis of chronic inflammatory skin diseases such as psoriasis and has been a target for 
the development of the new anti-psoriatic drug. Hence the present study aimed to evaluate inhibitory effects of ethanol 
extract of selected plants and isolated compound II, III and VI (5-40 mg/mL) on lipopolysaccharide (LPS) induced pro-
inflammatory cytokines viz., IL-1α, IL-1β, IL-6, IL-8, IL-17 and TNF-α production. The level of IL-1α, IL-1β, IL-6, IL-8, 
IL-17 and TNF-α pro-inflammatory cytokines were detected using enzyme-linked immunosorbent assay. The ethanol extract 
of both the plants was standardized by HPLC using chemical markers. Preincubation with isolated compounds II, III, VI and 
ethanol extract of selected plants strongly attenuated LPS-induced increase in the concentrations of IL-6 (50-73 %) and 
TNF-α (64-90 %). The compound II and III also showed significant inhibition (*p ≤0.05) of IL-1β, IL-8 and IL-17. The 
results showed that the selected plants and isolated flavonoids have potential effects as anti-inflammatory agents by 
inhibiting the release of pro-inflammatory cytokines supporting the folkloric utilization. 
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Introduction 
Psoriasis is a chronic inflammatory skin disease that 
can be considered as a T-cell mediated disease, with a 
complex role for a variety of cytokine interaction 
between keratinocytes and T-lymphocyte1. 
Keratinocytes secrete a number of cytokines and 
chemokines that either activate or suppress immune 
responses. In the psoriatic state, the epithelialization 
occurs in about 36 hours and so the division of 
keratinocytes which reduces to 10 days (240 hours). 
This phenomenon collectively leads to hyperkeratinized 
state2. The course of treatment available for treating 
psoriasis includes the use of the combinations of 
conventional methods like using coal tar preparations, 
dithranol, calcipotriol, topical corticosteroids and 
controlled UV radiations. However, serious side effects 
are associated with them. Systemic treatment is 
considered if extensive psoriasis fails to respond to local 
measures3. 
The serum TNF-α, IL-1, IL-6, IL-8, IL-12, and IL-
17 levels were significantly higher in active psoriatic 
patients than in controls. Regulation of the 
inflammatory events initiated or perpetuated by 
keratinocytes could so represent an important strategy 
for the treatment of psoriasis and other chronic 
inflammatory skin diseases. Interestingly, recent 
advances by cellular immunologist have identified 
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cytokines interleukins (IL) viz., IL-1α, IL-1β, IL-6, IL-
8, IL-17 and TNF- α that play an essential pathogenic 
role in psoriasis. Thus inhibition of TNF-α, IL-1α, IL-
1β, IL-6, IL-8, and IL-17 could be employed as criteria 
for the evaluation of antipsoriatic activity4.  
Recent literature data continue to support the fact 
that polyphenolic compounds, found in most plants, 
can have a positive effect on many chronic diseases. 
Natural polyphenols, recognized as potent 
antioxidants, are multifunctional molecules that can 
act as anti-inflammatory and antiproliferative agents 
through the modulation of multiple signalling 
pathways5. This characteristic could be advantageous 
for the treatment of multi-causal diseases, such as 
psoriasis. Polyphenols are ubiquitous constituents of 
plants and possess a broad spectrum of biological 
activities such as immune system activities, oxygen 
radical scavenging, antimicrobial, anti-inflammatory 
and antitumor activities6. The flavonoid quercetin 
exhibits anti-inflammatory effects mediated by the 
inhibition of the proinflammatory cytokine TNF-α via 
modulation of NF-κβ1 and Iκβ7. The flavone chrysin 
isolated from Potentilla evestita Th. Wolf. Possess 
anti-inflammatory supported in silico by an 
interaction with COX-2 binding site8.  
Natural plant compounds which are able to 
suppress the production of inflammatory mediators 
can act as potential anti-inflammatory agents. 
Therefore, this study is aimed to explore and evaluate 
the anti-inflammatory potential of flavonoids from the 
ethanol extract of Givotia rottleriformis Griff. ex 
Wight (Euphorbiaceae) bark and Cassia tora  
L. (Caesalpinaceae) leaves. G. rottleriformis is a 
moderately sized tree. The bark and seeds of the tree 
are used in indigenous medicine in the treatment of 
rheumatism, dandruff and psoriasis9. C. tora is a wild 
crop and grows in most parts of India as a weed. The 
leaves and seeds of the plant have been traditionally 
used for the treatment of psoriasis and other skin 
diseases10. Previous studies have demonstrated that 
the plants G. rottleriformis bark11 and C. tora leaves 
have antipsoriatic activity using in-vivo models12. 
These results prompted us to further investigate the 
species on the inhibitory effects on the IL-1α, IL-1β, 
IL-6, IL-8 and IL-17 and TNF-α biosynthesis. 
 
Materials and Methods 
Plant material 
The bark of the plant G. rottleriformis was 
collected from the forest of Attur, Salem district, 
Tamilnadu during the month of January 2011. C. tora 
leaves were collected in Chennai, Tamilnadu during 
the month of October 2011. It was identified and 
authenticated by Dr. P. Jayaraman, Director, Plant 
Anatomy Research Centre (PARC), Tambaram, 
Chennai. Voucher specimen No. PARC/2011/2140 
and PARC/2011/2141, respectively, have been 
deposited in Vels University for further reference. 
 
Extraction and isolation 
About 500 g of the powdered G. rottleriformis bark 
was extracted using a Soxhlet apparatus with ethanol 
(70 % v/v) (18 hours). The extracted solution was 
filtered and concentrated in a rotary evaporator under  
reduced pressure (rotary vacuum flash evaporator). 
The crude ethanol extract (25 g) thus obtained was 
subjected to chromatography (Silica gel 120 mesh, 
500 g) with gradient elution using solvents of 
increasing polarity, hexane, chloroform, ethyl acetate 
and methanol. Three flavonoid glycosides were 
isolated viz., Rutin (I), Luteolin-7-O-β-D-Glucuronide 
(II) and Kaempferol 3-O-[2-O-(6-O-feruloyl)-β-D-
glucopyranosyl]-β-D galactopyranoside (III).  
 
Phytochemical screening 
Phytochemical screening was performed to assess 
the qualitative chemical composition of crude extract 
using commonly employed precipitation and 
colouration reactions to identify the major secondary 
metabolites like alkaloids, flavonoids, glycosides, 
proteins, phenolic compounds, saponins, starch, 
steroids, tannins and terpenoids. Concentrated ethanol 
(70 %) extract of G. rottleriformis bark and C. tora 
leaves were screened for the presence of various 
phytoconstituents using standard procedure13. 
 
Fingerprint analysis by HPLC 
The Qualitative analysis of the sample was 
performed according to the method of Boligon et al14. 
The HPLC system of Jasco consists of a pump (model 
Jasco PU2080, intelligent HPLC pump) with injecting 
facility programmed at 20 µL capacity per injection 
was used. The detector consists of a UV/ VIS (Jasco 
UV 2075) model operated at a wavelength of 270 nm. 
The software used was Jasco Borwin version 1.5, LC-
Net II/ADC system. The column was Thermo ODS 
Hypersil C18 (250 x 4.6 mm, 5 µm) in isocratic mode. 
The separation was achieved using a mobile phase of 
methanol, water and phosphoric acid (100:100:1, 
v/v/v) at a flow-rate of 1.5 mL/min. The effluent was 
monitored using UV detection at a wavelength of 270 
nm. The mobile phase was filtered through 0.45µm 
nylon filter prior to use. 
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Sample preparation 
Powdered drug of G. rottleriformis bark was 
weighed (1 g) and transferred to a 250 mL flask fitted 
with a reflux condenser. About 78 mL of extraction 
solvent (Alcohol: Water and Hydrochloric acid 
(50:20:8) was added, refluxed on a hot water bath for 
135 minutes, cooled at room temperature and 
transferred to a 100 mL volumetric flask. About 20 
mL of methanol was added to the 250 mL flask, 
sonicated for 30 min, filtered and the filtrate was 
transferred to the 100 mL volumetric flask, the 
residue was washed on the filter with methanol. The 
washing was collected in the same 100 mL volumetric 
flask and diluted to volume. Identification is based on 
retention times and on-line spectral data in 
comparison with authentic standards. The procedure 
was repeated with powdered leaves of C. tora. 
 
Cytokine inhibition assay 
Endotoxin (LPS) from Escherichia coli 055:B5 
was obtained from Difco (Detroit, MI). Heparin was 
purchased from Takeda (Osaka, Japan) and ELISA 
kits from RayBio® (RayBiotech, Inc.).  
 
Blood collection 
About 20 mL of blood collected from healthy 
human volunteers after an overnight fast of 10–12 h. 
containing 20U heparin/mL by venapuncture and 30 
% solution is prepared by suspending in supplemented 
RPMI-1640 medium containing 100 U/mL penicillin 
and 100 mg/mL streptomycin. 
 
Procedure 
Lipopolysaccharide stimulated human peripheral 
mononuclear cells (LPS) (1 mg/mL) was dissolved in 
the supplemented RPMI-1640 media at a 
concentration of 3 mg/mL. The test samples, ethanol 
extract of G. rottleriformis bark and ethanol extract of 
C. tora leaves were dissolved in DMSO at 
concentrations of 5, 10, 20 and 40 mg/mL and each of 
these concentrations was diluted with the 
supplemented RPMI-1640 media (1:100). Only 
DMSO was contained in control suspension. Equal 
volumes from each of three solutions (whole blood, 
LPS and test sample) were mixed and the mixture was 
incubated at 37 °C in a humidified atmosphere of 95 
% air, 5 % CO2 for 18-24 hours. The supernatant of 
culture prepared by centrifugation was stored at  
-20 °C until the assay of cytokine. The concentrations 
of the human cytokines (IL-lα, IL-1β, IL-6, IL-8, IL-
17, TNF-α) were assayed using an ELISA kits15. The 
assays were performed as described in the 
manufacturer’s instructions. The ratio (%) of 
inhibition of the cytokine release was calculated by 
the following equation: 
 
Inhibition (%)= 100 × (1-T/C) 
 
where, T represents the concentration of the cytokine 
in the culture supernatant with the test compound, and 
C represents the concentration of the cytokine in the 
culture supernatant with the solvent (control). 
 
Statistical analysis 
The values of three separate sets of experiments are 
expressed as mean±S.D. The significance of 
differences between the respective controls was tested 
using Student’s t-test for each paired experiments.  
P ≤0.05 was considered as significant. 
 
Results and Discussion 
About 500 g of G. rottleriformis bark and C. tora 
powder was extracted using a soxhlet apparatus with 
ethanol (70 %) and the yield of ethanol extract of G. 
rottleriformis bark and C. tora powder was about 
12.50 % w/w and 11.36 % w/w. 
 
Phytochemical screening 
Preliminary phytochemical screening of ethanol 
extract of G. rottleriformis bark showed positive 
results for alkaloids (Dragendorff’s test), steroids 
(Liebermann-Burchard test), flavonoids (Shinoda’s 
test), tannins (Ferric chloride test), terpenoids 
(Salkowski’s test), and saponins (Foam test). The 
ethanol extract of C. tora leaves showed positive 
results for steroids (Liebermann-Burchard test), 
flavonoids (Shinoda’s test), tannins (Ferric chloride 
test), terpenoids (Salkowski’s test), carbohydrate 
(Molisch’s test) and anthraquinone glycoside 
(Borntrager’s test). 
 
HPLC analysis 
Qualitative analysis of the ethanol extract of the G. 
rottleriformis showed 7 components (Fig. 1). The 
main difference was in peak eluted at 3.96, 11.52, 
16.68 and 30.76 min, respectively. In the present 
investigation, 4 flavonoids were identified at 254 nm 
using peak area by comparison to a retention time of 
the standard marker, rutin, quercetin, kaempferol and 
luteolin (Fig. 2). Similarly, the ethanol extract of the 
C. tora leaves showed 13 components (Fig. 3). The 
main difference was in peak eluted at 12.07, 17.15, 
19.62 and 31 minutes, respectively and 4 flavonoids 
were identified at 254 nm using peak area by 
comparison to a retention time of the standard marker, 
luteolin, quercetin and formononetin (Fig. 4).  
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The results above showed, therefore, that the bark 
of G. rottleriformis and C. tora leaves was a rich 
source of the important biologically active flavonoids. 
The described HPLC procedure could be useful for 
the qualitative analysis of flavonoids in plant 
materials. 
 
Cytokine inhibition assay 
Inhibitory effects of the test samples on IL-lα, IL-
1β, IL-6, IL-8, IL-17 and TNF-α biosynthesis were 
given in Fig. 5 as the inhibitory percentages. For the 
interpretation of the results, percentage values were 
classified under four groups; an inhibition between 70 
and 100 % is accepted as high, values between 40 and  
69 % as moderate, 20 and 39 % as low and an 
inhibition less than 20 % is considered to be 
insignificant. 
Psoriasis can be described as a T-cell-mediated 
disease, with a complex role for a variety of cytokines 
and other factors. The interaction between T 
lymphocytes and keratinocytes, via cytokines, is 
likely to play a pivotal role in the pathogenic process 
in psoriasis. The Th1 cytokines (TNF-α, IFN-γ, and 
IL-12) and some proinflammatory cytokines (such as 
IL-6, IL-8, and IL-18) are influenced in the serum of 
psoriatic patients16. The exact role of TNF-α in the 
pathomechanism of psoriasis is still unclear, but anti-
TNF-α therapy is highly effective in psoriasis 
indicating that this cytokine has, together with IFN-γ, 
a central role in the pathogenesis. IFN-γ and TNF-α 
induce IL-6, IL-8, IL-12, and IL-18 and constitute an 
important link in the cytokine network in the 
pathogenesis of psoriasis17. Moreover, the intradermal 
administration of IFN-γ into the nonlesional skin of 
psoriatic patients causes the appearance of lesions at 
the inoculation site18. IL-6 mediates T cell activation, 
stimulates proliferation of keratinocytes19 and, at the 
beginning of acute inflammation, mediates the acute 
phase responses20. The IL-17 family is a key 
pathogenic messenger in the development of 
psoriasis. Binding of IL-17 to its receptor stimulates 
several activities on both structural skin cells as well 
as circulating and resident skin immune cells. In the 
case of psoriasis, keratinocyte hyperproliferation, 
maturation of myeloid dendritic cells, and recruitment 
and activation of neutrophils and macrophages are all 
IL-17 dependent activities. Collectively, these 
activities initiate and propagate the inflammation and 
architectural changes in the skin that manifest 
clinically as psoriatic lesions21,22. In fact, data 
currently available suggest that this cytokine exerts a 
critical role as a potent chemo-attractant for 
neutrophils and T lymphocytes, as well as a factor 
prompting keratinocyte proliferation. Weseler et al. 
reported that the flavones fisetin, morin, or tricetin 
attenuated LPS induced increases in concentrations of 
TNF-α in blood from COPD patients (chronic 
obstructive pulmonary disease) and IL-6 in blood 
from T2D patients (Type 2 diabetes), indicating a 
potential application as nutraceutical agents for this 
patient groups23. In an earlier work, Vijayalakshmi et al.24 
reported that the flavonoid quercetin showed a 
significant reduction in epidermal thickness with 
respect to control in Perry’s mouse tail model. 
 
Fig. 1 — HPLC fingerprint of ethanol extract of Givotia 
rottleriformis bark 
 
 
Fig. 2 — HPLC fingerprint of reference standards 1: Rutin 2: 
Quercetin 3: Kaempferol 4: Luteolin. 
 
 
 
Fig. 3 — HPLC fingerprint of ethanol extract of Cassia tora 
leaves  
 
 
Fig. 4 — HPLC fingerprint of reference standards 1: Quercetin 2: 
Kaempferol 3: Formononetin 4: Luteolin  
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Jadranka Skuric et al.25 reported that the flavonoids 
from propolis offer some protection against psoriatic 
complications through their roles as inhibitors of 
inflammation and as free radical scavengers on animal 
model psoriasis, induced by the Di-n-Propyl Disulfide 
iritant (PPD). 
In the present study, the ethanol extract of the bark 
of G. rottleriformis, C. tora leaves showed 
remarkable inhibition of IL-6 and TNF-α release at 
higher concentration and flavonoid glycosides 
Luteolin, Kaempferol and Formononetin showed high 
percentage of inhibition of IL-1β, IL-6, IL-8, IL-17 
and TNF- α, key cytokines involved in the 
pathogenesis of psoriasis in ex vivo LPS-stimulated 
blood.  
 
Conclusion 
In conclusion, the study demonstrated that the 
ethanol extract of the plants G. rottleriformis, C. tora 
and flavonoid glycosides Luteolin, Kaempferol and 
Formononetin were able to attenuate LPS-induced 
cytokine release and may provide safe and effective 
treatment options for a variety of inflammation-
mediated diseases such as psoriasis. However, 
additional clinical investigation of these compounds is 
indicated to evaluate the efficacy and safety of their 
application as dietary supplements with health 
benefits to psoriatic patients.  
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